NEW YORK, Nov. 30, 2015 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All Persons or Entities who purchased Liberator Medical Holdings, Inc. (NYSE MKT:LBMH) stock prior to November 20, 2015.
You are hereby notified that a class action has been has commenced in Nevada state court challenging the fairness of the sale of Liberator Medical Holdings, Inc. to C. R. Bard, Inc. (NYSE:BCR) for $3.35 in cash per share. The claims stem from concerns that the Board of Liberator Medical may have breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and that C. R. Bard, Inc. may be underpaying for Liberator Medical shares. In particular, at least one analyst set a price target of $8.00 per Liberator Medical share. To learn more about the investigation and your rights, go to:
http://zlk.9nl.com/liberator-medical-lbmh
or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.
Levi & Korsinsky, LLP Joseph Levi, Esq. Eduard Korsinsky, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com


Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Cybersecurity Stocks Tumble After Anthropic's Claude Mythos AI Leak Sparks Market Fears
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
Brown-Forman and Pernod Ricard in Merger Talks to Create World's Largest Spirits Giant
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Unilever and Magnum Face Defamation Lawsuit Over Ben & Jerry's Board Chair Dismissal
Novartis to Acquire Biotech Firm Excellergy in $2 Billion Deal
BlackRock CEO Larry Fink Earns $37.7 Million in 2025 Amid Record Growth
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Apple Turns 50: From Garage Startup to AI Crossroads
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
Bank of America's $72.5M Epstein Settlement: What You Need to Know
Brazil Meat Exports Weather Iran War Disruptions With Rerouted Shipments
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition 



